Insights into pharmacotherapy of malignant glioma in adults
- PMID: 19663635
- DOI: 10.1517/14656560903146910
Insights into pharmacotherapy of malignant glioma in adults
Abstract
Malignant gliomas are the most common primary brain tumors in adults. In the past 10 years significant advances in the treatment of this entity have been made, mainly owing to a better understanding of molecular pathways and biological behavior of the oncogenetic process. This review treats the proven effective and promising approaches with chemotherapy. The standard care for glioblastoma is surgery and concomitant radio- and chemotherapy with temozolomide (TMZ), followed by adjuvant treatment with TMZ. It has been demonstrated to be the most effective treatment protocol. This standardized care allows the application and study of new types of treatment mainly in recurrences and nonresponding patients. Many different approaches have been investigated: the combination of cytotoxic and cytostatic agents as well as molecular targeted therapies have given some encouraging results. Further intensified regimens with TMZ and the local postsurgical application of slow-release polymers loaded with carmustine remain to be defined. The characterization of molecular markers thus becomes particularly important for the stratification of patients raising the possibility to individualize treatment.
Similar articles
-
Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma.Ann Oncol. 2010 Aug;21(8):1723-1727. doi: 10.1093/annonc/mdp591. Epub 2010 Jan 11. Ann Oncol. 2010. PMID: 20064829
-
[Association of radiotherapy and chemotherapy-targeted therapies in glioblastomas].Bull Cancer. 2009 Mar;96(3):291-7. doi: 10.1684/bdc.2009.0835. Bull Cancer. 2009. PMID: 19318307 Review. French.
-
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.J Clin Oncol. 2010 Apr 20;28(12):2051-7. doi: 10.1200/JCO.2009.26.5520. Epub 2010 Mar 22. J Clin Oncol. 2010. PMID: 20308655 Clinical Trial.
-
Chemotherapy and target therapy in the management of adult high- grade gliomas.Curr Cancer Drug Targets. 2012 Oct;12(8):1016-31. doi: 10.2174/156800912803251207. Curr Cancer Drug Targets. 2012. PMID: 22831277 Review.
-
New chemotherapy options for the treatment of malignant gliomas.Anticancer Drugs. 2007 Jul;18(6):621-32. doi: 10.1097/CAD.0b013e32801476fd. Anticancer Drugs. 2007. PMID: 17762390 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous